The population effect of a national policy to incentivize chronic disease management in primary care in stroke: a population-based cohort study using an emulated …

NE Andrew, D Ung, MT Olaiya, LL Dalli… - The Lancet Regional …, 2023 - thelancet.com
Background Governments are investing in primary care policies that support chronic disease
management. Large scale population-based evaluations are lacking. We aim to determine …

Antihypertensive medication adherence and the risk of vascular events and falls after stroke: a real-world effectiveness study using linked registry data

LL Dalli, MT Olaiya, J Kim, NE Andrew, DA Cadilhac… - …, 2023 - Am Heart Assoc
Background: Real-world evidence is limited on whether antihypertensive medications help
avert major adverse cardiovascular events (MACE) after stroke without increasing the risk of …

One-year medication adherence and persistence in rheumatoid arthritis in clinical practice: a retrospective analysis of upadacitinib, adalimumab, baricitinib, and …

M Bergman, N Chen, R Thielen, P Zueger - Advances in Therapy, 2023 - Springer
Introduction This study evaluated 12 months adherence and persistence among Janus
kinase inhibitors (upadacitinib, baricitinib, tofacitinib) and adalimumab, a tumor necrosis …

Use of secondary prevention medications in metropolitan and non-metropolitan areas: an analysis of 41 925 myocardial infarctions in Australia

AC Livori, Z Ademi, J Ilomäki, D Pol… - European Journal of …, 2024 - academic.oup.com
Aims People in remote areas may have more difficulty accessing healthcare following
myocardial infarction (MI) than people in metropolitan areas. We determined whether …

Learning health system linchpins: information exchange and a common data model

AS Eisman, ES Chen, WC Wu… - Journal of the …, 2025 - academic.oup.com
Objective To demonstrate the potential for a centrally managed health information exchange
standardized to a common data model (HIE-CDM) to facilitate semantic data flow needed to …

[HTML][HTML] Patterns of 12-month post-myocardial infarction medication use according to revascularisation strategy: Analysis of 15,339 admissions in Victoria, Australia

AC Livori, Z Ademi, J Ilomäki, AJ Nelson, JS Bell… - Heart, Lung and …, 2024 - Elsevier
Aim Clinical guidelines recommend secondary prevention medications following myocardial
infarction (MI) regardless of revascularisation strategy. Studies suggest that there is variation …

The influence of intervention fidelity on treatment effect estimates in clinical trials of complex interventions: a metaepidemiological study

A Páez, D Nunan, P McCulloch, D Beard - Journal of Clinical Epidemiology, 2025 - Elsevier
Abstract Background and Objective Randomized clinical trials (RCTs) provide the most
reliable estimates of treatment effectiveness for therapeutic interventions. However, flaws in …

Is statin therapy after ischaemic stroke associated with increased intracerebral hemorrhage? The association may be dependent on intensity of statin therapy

R Yang, J Wu, H Yu, S Wang, H Chen… - … Journal of Stroke, 2023 - journals.sagepub.com
Background: There has been concern that statin therapy may be associated with an
increased risk of intracerebral hemorrhage (ICH). We investigated whether the intensity and …

The role of ambulatory blood pressure monitoring in enhancing medication adherence among patients with newly diagnosed hypertension: an analysis of the National …

HL Kim, SJ Park, YJ Bae, SH Ihm, J Shin, KI Kim - Clinical Hypertension, 2024 - Springer
Background Improving adherence to antihypertensive medication (AHM) is a key challenge
in hypertension management. This study aimed to assess the impact of ambulatory blood …

Effect of Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study

AR Barry, H Helisaz, A Safari… - Journal of the American …, 2024 - Am Heart Assoc
Background The effect of angiotensin‐converting enzyme inhibitors/angiotensin receptor
blockers (ACEI/ARBs) on major adverse cardiovascular events (MACE) in patients who …